Meglumine Gadoterate

5 trials 1 recruiting VVarious

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

1 Recruiting

3 Completed trials

5 Sponsors

12 Countries

Phase III

Phase II

Phase III: 2 Phase II: 3

Sponsors using this IMP

Aarhus Universitet 1 Assistance Publique Hopitaux De Paris 1 Eli Lilly & Co. 1 Fundacio Sant Joan De Deu 1 Novo Nordisk A/S 1

All trials

5 total

Improving Heart Scans in Children: A Study Comparing Two Contrast Agents for MRI Pending

2025-524029-41-00 Phase III 1 country Fundacio Sant Joan De Deu
DASSOH - Systematic use of DDAVP to prevent serum sodium overcorrection in severe hyponatremia : a multicenter open-label randomized control… Recruiting

2023-507254-32-00 Phase III 1 country Assistance Publique Hopitaux De Paris
HOPE in Diabetic Kidney Disease (HyperpOlarised PyruvatE in Diabetic Kidney Disease) Ended

2023-508824-36-00 Phase II 1 country Aarhus Universitet
A research study to look at long-term treatment with a medicine called NNC6019-0001 for people who have heart failure due to transthyretin a… Ended

2022-502605-15-00 Phase II 7 countries Novo Nordisk A/S
“A Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis” Ended

2023-503289-22-00 Phase II 7 countries Eli Lilly & Co.

Showing 1–5 of 5 trials

← All drugs A–Z